What This Document Is
This document is a review resource for the second pharmacology exam (PHARM 201) at Fortis College. It focuses on key medications and concepts related to antidepressants and antipsychotics, along with associated adverse effects and critical safety considerations. It’s designed to help students consolidate their understanding of these drug classes in preparation for assessment.
Why This Document Matters
This review is essential for Fortis College Pharmacology students preparing for their second exam. A strong grasp of antidepressant and antipsychotic pharmacology is foundational for future clinical practice, impacting medication selection, patient monitoring, and safety. This document serves as a focused refresher on frequently tested material. It’s most useful when used *in conjunction with* course lectures, textbooks, and other learning materials.
Common Limitations or Challenges
This review is not a substitute for comprehensive study. It provides highlights and key points but does not cover the full breadth of information presented in the course. It does not include practice questions or detailed mechanisms of action beyond what is stated. Students should not rely solely on this document to pass the exam.
What This Document Provides
This review includes information on:
* Specific antidepressants: Sertraline (Zoloft), Bupropion (Wellbutrin/Zyban) and Tricyclic Anti-Depressants (amitriptyline, nortriptyline, imipramine) – including common side effects and special considerations.
* MAOI (Monoamine Oxidase Inhibitor) medications, with a memory aid for brand name recognition and critical dietary restrictions.
* Serotonin Syndrome – including symptoms and potential complications.
* Antipsychotic medications – including side effects, mechanisms, and a discussion of Extrapyramidal Symptoms and Neuroleptic Malignant Syndrome.
* Information regarding Clozapine and its associated monitoring requirements.
This preview does *not* include detailed drug interactions, dosage guidelines, or comprehensive coverage of all possible adverse effects. It also does not include any practice questions or case studies.